|
Mean specific activity of Total GST in nmol/min/mg of protein (Ratio of the treated/control enzyme specific activities, 95% Confidence Intervals) |
|||||
| Sulforaphane |
BNF |
Curcumin |
DMF |
Control |
|
|
|
|||||
| Liver |
956 (1.6, 1.4–1.7)* |
815 (1.4, 1.2–1.5)* |
739 (1.2, 1.1–1.4)* |
679 (1.1, 1.03–1.2)* |
602 |
| Kidney |
92.5 (1.2, 1.0–1.3) |
80 (1.0, 0.77–1.3) |
65 (0.81, 0.67–1.0) |
89 (1.1, 0.96–1.3) |
81 |
| Prostate |
6.7 (1.2, 1.1–1.5)* |
5.7 (1.06, 1.0–1.1) |
6.9 (1.3,1.2–1.4)* |
7.0 (1.3, 1.0–1.7) |
5.4 |
| Bladder |
0.78 (4.2, 3.6–4.9)* |
0.26 (1.4, 0.81–2.3) |
0.28 (1.5, 0.96–2.3) |
0.29 (1.5, 0.99–2.4) |
0.19 |
|
Data are mean values of 8–10 animals in each group * = P < 0.05 based on confidence intervals of the ratio of treated vs. control total GST specific activities | |||||
Jones and Brooks BMC Cancer 2006 6:62 doi:10.1186/1471-2407-6-62 |
|||||